A study analyzing clinical, serological and pathological features of a large number of patients with acute hepatitis after COVID-19 vaccination
Latest Information Update: 23 Aug 2022
At a glance
- Drugs AZD 1222 (Primary) ; Coronavirus vaccine-Wuhan Institute of Biological Products (Primary) ; COVID-19 vaccine-Gamaleya National Research Center of Epidemiology and Microbiology (Primary) ; Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
- Acronyms ERN RARE-LIVER
Most Recent Events
- 23 Aug 2022 New trial record
- 26 Jun 2022 Results presented at The International Liver Congress 2022